Rvl Pharmaceuticals Plc (RVLP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 114,053 | 126,093 | 140,376 | 125,830 | 95,865 |
| Receivables | 3,149 | 21,569 | 17,024 | 32,644 | 43,914 |
| Inventories | 1,831 | 21,703 | 20,301 | 20,536 | 21,305 |
| Other current assets | 41,529 | 0 | 0 | 0 | 0 |
| TOTAL | $173,154 | $176,170 | $186,792 | $189,664 | $172,630 |
| Non-Current Assets | |||||
| PPE Net | 2,391 | 28,664 | 29,281 | 29,987 | 30,238 |
| Intangibles | 90,937 | 218,759 | 242,498 | 250,479 | 254,841 |
| Other Non-Current Assets | 104,467 | 3,653 | 4,126 | 5,004 | 5,546 |
| TOTAL | $197,795 | $251,076 | $275,905 | $285,470 | $290,625 |
| Total Assets | $370,949 | $427,246 | $462,697 | $475,134 | $463,255 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,128 | 7,909 | 8,798 | 8,784 | 8,495 |
| Accrued Expenses | 16,951 | 45,376 | 48,353 | 47,256 | 65,253 |
| Other current liabilities | 34,484 | N/A | N/A | N/A | N/A |
| TOTAL | $55,784 | $54,946 | $58,890 | $58,154 | $75,937 |
| Non-Current Liabilities | |||||
| Long Term Debt | 219,525 | 219,290 | 268,522 | 268,236 | 267,950 |
| Other Non-Current Liabilities | 1,439 | 1,790 | 2,175 | 2,646 | 3,116 |
| TOTAL | $221,309 | $221,614 | $272,896 | $273,240 | $272,610 |
| Total Liabilities | $277,093 | $276,560 | $331,786 | $331,394 | $348,547 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 62,719 | 62,586 | 63,783 | 58,899 | 58,899 |
| Common Shares | 625 | 631 | 588 | 589 | 518 |
| Retained earnings | -452,610 | -397,736 | -389,103 | -376,104 | -373,021 |
| Other shareholders' equity | -2,229 | -2,229 | -2,229 | -2,229 | -2,229 |
| TOTAL | $93,856 | $150,686 | $130,911 | $143,740 | $114,708 |
| Total Liabilities And Equity | $370,949 | $427,246 | $462,697 | $475,134 | $463,255 |